PubRank

Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

Clinical Trial ID NCT02551744

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02551744

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 20.20
2 Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006 18.25
3 A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 16.32
4 Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001 8.54
5 Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2008 8.39
6 Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009 7.78
7 Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010 7.39
8 Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005 6.39
9 A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009 6.21
10 Drug-drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 2009 1.92
11 Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 2009 1.80
12 Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004 1.79
13 Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007 1.67
14 Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. Gastroenterology 2010 1.62
15 Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A 2001 1.39
16 Clopidogrel: a review of its mechanism of action. Platelets 1998 1.05
17 Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol 2009 0.97
18 Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scand J Gastroenterol 2000 0.92
19 High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003 0.87
20 P2Y receptor antagonists in thrombosis. Curr Opin Investig Drugs 2005 0.84
21 Risk of combining PPIs with thienopyridines: fact or fiction? Lancet 2009 0.77
Next 100